GenXAI Analytics is entering the SME market with a fresh issue of 47,28,000 equity shares, seeking to mobilise up to ₹54.66 crore at the upper end of the price band. Subscriptions are scheduled to begin on 5 June 2026 and conclude on 9 June 2026. The basis of allotment is expected on 10 June 2026. Subject to completion of the issue process, the shares are proposed to commence trading on NSE Emerge on 12 June 2026.
The offer carries a price band of ₹110 to ₹116 per share. Applications must be submitted in multiples of 1,200 shares. Individual investors are required to apply for at least 2,400 shares, involving ₹2,78,400 at the cap price. The minimum application for the S NII category stands at ₹4,17,600 for 3,600 shares, while the B NII threshold begins at ₹11,13,600 for 9,600 shares.
Genxai Analytics IPO Details
The IPO is entirely a fresh issue. The offer details are provided below:
| Particulars | Details |
| IPO Open Date | 5 June 2026 |
| Close Date | 9 June 2026 |
| Face value | ₹10 per equity share |
| Price Band | ₹110- ₹116 per equity share |
| Issue price | Yet to be finalised |
| IPO Lot Size | 1,200 equity shares; minimum application size is 2,400 shares |
| Offer for sale | – |
| Fresh issue | Up to 47,28,000 equity shares |
| Issue Type | Book-Built SME IPO |
| Listing at | NSE Emerge |
| Total Issue Size | ₹52.01 crore to ₹54.84 crore |
| Minimum Investment | ₹2,78,400 for 2,400 equity shares at the upper price band |
Genxai Analytics IPO Timeline
The issue is scheduled to move from subscription opening to proposed listing within a short post-closure window. Its key dates are set out below:
| Particulars | Details |
| Bidding Opens | 5 June 2026 |
| Bidding Closes | 9 June 2026 |
| Allotment Expected | 10 June 2026 |
| Refunds Start On | 11 June 2026 |
| Share Credit to Demat | 11 June 2026 |
| Listing Scheduled | 12 June 2026 |
| Cut-off for UPI mandate | 5:00 p.m. on 9 June 2026 |
Genxai Analytics Key Performance Indicators (KPI)
GenXAI Analytics reported stronger profitability ratios. the company’s key performance indicators are set out below:
| KPIs | FY25 | FY24 | FY23 |
| ROE (%) | 85.49% | 85.57% | 95.16% |
| ROCE (%) | 70.26% | 70.70% | 71.25% |
| Debt Equity (times) | 0.66x | 0.93x | 0.46x |
| RoNW (%) | 85.49% | 85.57% | 60.73% |
| PAT Margin (%) | 23.16% | 11.02% | 5.09% |
| EBITDA Margin (%) | 35.14% | 17.14% | 8.57% |
| Price Book Value |
Genxai Analytics Financials
The figures below trace GenXAI Analytics’ income, asset base and earnings over FY23 to FY25:
| Particulars (in ₹ lakh) | FY25 | FY24 | FY23 |
| Total Assets | ₹16.61 crore | ₹24.21 crore | ₹28.88 crore |
| Revenue | ₹6.75 crore | ₹11.33 crore | ₹23.61 crore |
| Profit | ₹0.84 crore | ₹2.65 crore | ₹6.55 crore |
Genxai Analytics IPO Subscription Status
| Date | QIB (Ex Anchor) | NII* | Individual Investors | Total |
|---|---|---|---|---|
| Jun 5 (Day 1) | 0.50 | 1.24 | 0.42 | 0.60 |
| Jun 8 (Day 2) | 0.50 | 1.24 | 0.71 | 0.74 |
Genxai Analytics IPO Grey Market Premium
GenXAI Analytics IPO GMP is ₹11 as of 2 June 2026. The GMP reached ₹15 on 31 May before easing to ₹11, where it has remained unchanged on the latest reported date.
| GMP Date | GMP | Est. Listing Price | Est. Profit* | Last Updated |
|---|---|---|---|---|
| 08-06-2026 | ₹3 ─ | ₹119 (2.59%) | ₹3,600 | 8-Jun-2026 11:34 |
| 07-06-2026 | ₹3 ─ | ₹119 (2.59%) | ₹3,600 | 7-Jun-2026 23:28 |
| 06-06-2026 | ₹3 ─ | ₹119 (2.59%) | ₹3,600 | 6-Jun-2026 23:35 |
| 05-06-2026 Open | ₹3 ▼ | ₹119 (2.59%) | ₹3,600 | 5-Jun-2026 23:32 |
| 04-06-2026 | ₹10 ▲ | ₹126 (8.62%) | ₹12,000 | 4-Jun-2026 23:31 |
| 03-06-2026 | ₹8 ▼ | ₹124 (6.90%) | ₹9,600 | 3-Jun-2026 23:28 |
| 02-06-2026 | ₹11 ─ | ₹127 (9.48%) | ₹13,200 | 2-Jun-2026 23:31 |
| 01-06-2026 | ₹11 ▼ | ₹127 (9.48%) | ₹13,200 | 1-Jun-2026 23:33 |
| 31-05-2026 | ₹15 ▲ | ₹131 (12.93%) | ₹18,000 | 31-May-2026 23:29 |
| 30-05-2026 | ₹13 ▲ | ₹129 (11.21%) | ₹15,600 | 30-May-2026 23:28 |
| 29-05-2026 | ₹0 ─ | ₹116 (0.00%) | ₹0 | 29-May-2026 23:29 |
Note: GMP values arise from unofficial grey market activity and may change rapidly with shifts in demand, subscription levels and market sentiment. They indicate prevailing market expectations and do not confirm the actual listing price or subsequent performance.
Genxai Analytics IPO Reservation
The allocation framework distributes the issue among institutional, non-institutional, individual, employee, and market maker categories, as detailed below.
| Category | Shares Offered |
| Market Maker Shares Offered | 2,40,000 equity shares |
| Employee Shares Offered | 1,80,000 equity shares |
| QIB Shares Offered | Not more than 21,54,000 equity shares |
| NII (HNI) Shares Offered | Not less than 6,46,200 equity shares |
| Retail Shares Offered | Not less than 15,07,800 equity shares |
| Total Shares Offered | 47,28,000 equity shares |
Genxai Analytics IPO Lot Size
At the cap price, individual participation begins with two lots, requiring an outlay of ₹2,78,400. The application thresholds for each investor class are presented in the table below.
| Application Category | Lots | Shares | Amount |
| Individual Investors Retail Minimum | 2 | 2,400 | ₹2,78,400 |
| Individual Investors Retail Maximum | 2 | 2,400 | ₹2,78,400 |
| S HNI Minimum | 3 | 3,600 | ₹4,17,600 |
| S HNI Maximum | 7 | 8,400 | ₹9,74,400 |
| B HNI Minimum | 8 | 9,600 | ₹11,13,600 |
Genxai Analytics IPO Anchor Investors
The table outlines the anchor allocation particulars available for the offer.
| Particulars | Details |
| Anchor Bidding Opens | 4 June 2026 |
| Shares Offered | Up to 12,92,400 equity shares |
| Portion Size | To be confirmed |
| 50% Shares Lock-in (30 Days) | To be updated |
| Remaining shares Lock-in (90 Days) | To be updated |
Genxai Analytics IPO Prospectus
For more information on the issue, please go through the documents mentioned below.
| Draft Red Herring Prospectus (DRHP) | |
| Addendum to DRHP | |
| Red Herring Prospectus (RHP) | |
| Anchor Investors | – |
| Final Prospectus | Not Disclosed Yet |
About Genxai Analytics
Incorporated in 2007 as Harbinger Consulting Private Limited, the enterprise later underwent name changes before adopting its present identity and becoming a public limited company in 2025.
| Particulars | Details |
| Founded in | 12 June 2007 |
| Managing Director | Rakesh Agarwal |
Its operations centre on technology services that assist businesses in planning, financial analysis, process management and reporting. The offering extends across corporate functions such as finance, sales, operations, customer management and human resources.
The portfolio includes Enterprise Performance Management solutions on the Anaplan platform and Enterprise Resource Planning assignments within the SAP ecosystem. Its capabilities also cover data engineering, analytical solutions, software applications and generative artificial intelligence tools.
The client base extends across financial services, healthcare, manufacturing, technology, media, telecommunications, consumer goods, retail and the public sector.
| Lead Manager | Choice Capital Advisors Private Limit |
| IPO Registrar | Bigshare Services Private Limited |
Genxai Analytics IPO Objectives
The public issue consists solely of newly issued shares. The proposed deployment of proceeds is outlined below:
| Objective | Proposed Utilisation |
| Working capital requirements | ₹7.20 crore |
| Repayment or prepayment of outstanding borrowings | ₹3.00 crore |
| Capital expenditure for development of new products | ₹28.37 crore |
| General corporate purposes | Remaining proceeds within the applicable regulatory limit |
Strengths of Genxai Analytics
Genxai Analytics’ business operations are driven by the following strengths:
Presence in enterprise planning solutions
The issuer has been associated with Anaplan since 2019. This supports its position in an area where corporations use integrated planning systems for budgeting, forecasting and performance oversight.
Diversified technology capabilities
Its service suite extends beyond a single platform or function. Expertise in enterprise planning, resource management systems, analytics, software development and artificial intelligence allows the business to address several organisational requirements.
Continuity in customer engagements
During FY25, customers associated with the enterprise across at least three reporting periods contributed 74.11% of revenue from operations. This suggests that a considerable portion of income arose from continuing commercial relationships.
Early development of proprietary products
The firm has introduced solutions relating to invoice processing, sales incentive management and enterprise applications of generative artificial intelligence. These offerings accounted for 1.18% of revenue from operations in FY25 and 4.04% during the nine months ended 31 December 2025, reflecting a developing rather than established revenue segment.
Risks of Genxai Analytics
A careful review of the potential risks surrounding Genxai Analytics is necessary before taking an investment call.
Dependence on key customers
The ten largest customers generated 65.23% of revenue from operations in FY25, while the leading account contributed 19.38%. Any material reduction in business from major clients could affect financial performance.
Reliance on international revenue
A significant portion of income is earned from overseas markets, including the United States. Changes in economic conditions, regulation, currency movement or international trade dynamics may influence order flow and profitability.
Technological obsolescence
Artificial intelligence and enterprise software continue to evolve at speed. Newer tools, shifting client expectations or competing delivery models may require further investment and diminish the relevance of existing solutions.
Uncertain returns from new product expenditure
The offer assigns substantial capital to the creation of new products. Market acceptance, commercial scale and revenue conversion remain subject to execution, competition and customer adoption.
Genxai Analytics IPO Review
GenXAI Analytics IPO provides access to an enterprise technology firm engaged in planning platforms, analytics, ERP services and artificial intelligence applications. Its prospects draw support from a broad service portfolio and engagements across several industries. The grey market, on its latest available reading, points to restrained expectations for the market debut.
Principal concerns include dependence on major clients, overseas income exposure, rapid technological change and uncertain commercial returns from new product development. The issue may be examined by investors who understand the liquidity, volatility and execution risks associated with SME listed technology businesses.
Other Recent IPO List
Interested in more IPO options? Browse through the latest and upcoming public offerings.
| Q-Line Biotech IPO | Bio Medica Laboratories IPO |
| Autofurnish IPO | Yaashvi Jewellers IPO |
| SMR Jewels IPO | Merritronix IPO |
| M R Maniveni Foods IPO | Harikanta Overseas IPO |
Genxai Analytics IPO FAQs
It is a book built SME offering of up to 47,28,000 fresh equity shares. The stock is proposed to list on NSE Emerge.
Bids can be placed through a broker or banking platform supporting public issue applications. The amount remains blocked through ASBA or a valid UPI mandate.
The issuer operates in analytics and artificial intelligence-led enterprise services. Its prospects should be weighed against customer concentration, overseas exposure, and SME market risk.
Returns cannot be known before market trading begins. Grey market readings may indicate sentiment, but they do not assure listing performance.
Bidding is scheduled to begin on 5 June 2026. The offer is due to close on 9 June 2026.
One lot consists of 1,200 shares. The minimum individual application is 2,400 shares, requiring ₹2,78,400 at the cap price.
An applicant needs an active demat account and an eligible payment route. The bid may be submitted through ASBA or supported UPI facilities.
The basis of allotment is tentatively scheduled for 10 June 2026. The date remains subject to the completion of issue formalities.
Trading is provisionally expected to begin on 12 June 2026. The proposed platform is NSE Emerge.
